Envoy Medical, Inc. COCH
0.72
0.00
0.00%
as of 25 Sep
- Market cap
- $55.4M
- P/E
- 0.0×
Follow COCH
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '17 | |
|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
P/S ratio |
63.70 | 119.42 | 73.54 | 0.00 | — | — | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
P/Operating CF |
(2.70) | (5.28) | (2.09) | (42.64) | — | — | — |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
EV/Sales |
175.25 | 190.19 | 174.39 | 0.00 | — | — | — |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
EV/Operating CF |
(2.32) | (2.38) | (3.22) | (15.46) | — | — | — |
EV/FCF |
(2.30) | (2.26) | (3.20) | (15.46) | — | — | — |
Quick Ratio |
0.33 | 0.84 | 0.61 | 0.09 | 0.06 | 0.26 | — |
Current Ratio |
0.54 | 1.18 | 1.02 | 0.65 | 0.32 | 0.26 | — |
Net Debt/EBITDA |
0.18 | (0.73) | 0.24 | (3.85) | 0.03 | 35.71 | — |
Debt/Assets |
0.00% | 162.21% | 0.00% | 1,306.61% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | (0.99) | 0.00 | (0.92) | 0.00 | 0.00 | — |
Asset Turnover |
0.02 | 0.02 | 0.06 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.64 | 0.64 | 0.55 | 0.55 | 12.88 | 0.00 | — |
Capex/Depreciation |
(0.14) | (0.80) | (0.21) | (2.91) | 0.00 | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| 184.92% | 271.35% | 164.71% | 43.68% | 1.37% | 0.00% | — | |
| (285.25%) | (282.43%) | (577.65%) | (7.42%) | (0.12%) | (1.17%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Return on Tangible Assets |
674.72% | (1,062.40%) | (5,990.61%) | 2,948.70% | 13.86% | 0.99% | — |
Average Days of Receivables |
80.27 | 1,326.98 | 284.15 | 63.14 | — | — | — |
Research and Development Expense of Revenue |
5,180.91% | 4,524.00% | 2,834.18% | 2,099.16% | — | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
3,797.10% | 3,804.44% | 2,825.95% | 1,464.14% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
309.13% | 249.78% | 498.42% | 0.00% | — | — | — |
Graham Net Nets |
(0.94) | (0.80) | (0.11) | (0.37) | — | — | — |
Graham Number |
3.79 | 5.64 | 2.83 | 11.25 | — | — | — |
Earnings Yield |
(184.85%) | (98.60%) | (129.98%) | (15.70%) | — | — | — |
Free Cash Flow Yield |
(119.73%) | (70.52%) | (74.21%) | (8.68%) | — | — | — |
Revenue per Share |
0.01 | 0.01 | 0.03 | 0.02 | 0.00 | 0.00 | — |
Operating CF per Share |
(0.78) | (0.96) | (1.39) | (0.87) | (0.31) | 0.00 | — |
Capex per Share |
(0.01) | (0.05) | (0.01) | (0.02) | 0.00 | 0.00 | — |
Free Cash Flow per Share |
(0.79) | (1.01) | (1.40) | (0.89) | (0.31) | 0.00 | — |
Cash per Share |
0.16 | 0.29 | 0.34 | 0.02 | 0.01 | 0.00 | — |
Shareholders Equity per Share |
(0.52) | (1.00) | (0.14) | (3.58) | (3.47) | 0.00 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
(0.52) | (1.00) | (0.14) | (3.58) | (3.47) | 0.00 | — |
Free Cash Flow |
(18.38) | (18.93) | (17.24) | (9.02) | (3.24) | 0.00 | — |
Working Capital |
(5.28) | 1.36 | 0.17 | (0.87) | (1.81) | (0.07) | — |
Capital Expenditures |
(0.18) | (0.98) | (0.15) | (0.22) | — | 0.00 | — |
Net Current Asset Value |
(14.44) | (21.48) | (2.59) | (37.10) | (462.75) | (0.07) | — |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Capex to Sales |
0.74 | 4.36 | 0.48 | 0.92 | — | 0.00 | — |
Net Profit Margin |
(11,892.95%) | (12,432.44%) | (9,895.89%) | (6,718.57%) | 0.00% | 0.00% | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
| Other line items | |||||||
Depreciation/Fixed assets |
1.22 | 0.96 | 2.09 | 0.23 | 0.00 | 0.00 | — |
Cash ROIC |
228.48% | (358.86%) | (714.25%) | 349.37% | 8.86% | 0.00% | — |
Accounts Receivable Turnover |
0.55 | 0.42 | 2.20 | 0.00 | — | — | — |
Accounts Payable Turnover |
0.38 | 0.46 | 0.62 | 0.61 | 0.00 | 0.00 | — |
Inventory Turnover |
0.54 | 0.48 | 0.58 | 0.00 | — | — | — |
Average Days of Payables |
1,219.45 | 812.64 | 718.90 | 735.13 | 0.00 | 0.00 | — |
Days of Inventory on Hand |
645.64 | 840.19 | 649.51 | 949.15 | — | — | — |
Average Receivables |
0.44 | 0.53 | 0.14 | — | — | — | — |
Average Payables |
2.29 | 1.60 | 1.28 | 0.81 | 0.36 | 0.36 | — |
Average Inventory |
1.63 | 1.56 | 1.35 | — | — | — | — |
Average Assets |
10.05 | 9.90 | 5.41 | 214.73 | 213.51 | 0.06 | — |
Average Common Equity |
(15.50) | (10.31) | (18.99) | (36.45) | (18.34) | 194.16 | — |
Columns are period end dates